Pharmacological Study of TA-0910, a New Thyrotropin-Releasing Hormone (TRH) Analog (IV): Effects on Experimental Memory Impairment in Mice and Rats

The Japanese Journal of Pharmacology

Volumn 55, Issue 2, 1991, Pages 241-253

  Yamamura, Michio ^a   Kinoshita, Kiyoshi ^a   Nakagawa, Hiroyuki ^a   Ishida, Ryuichi ^a  

^a MITSUBISHI TANABE PHARMA CORPORATION   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROTIRELIN; PROTIRELIN DERIVATIVE; SCOPOLAMINE; TALTIRELIN;

AMNESIA; ANIMAL MODEL; ARTICLE; AVOIDANCE BEHAVIOR; BRAIN INJURY; CONTROLLED STUDY; FOREBRAIN; HISTOLOGY; INSTRUMENTAL CONDITIONING; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MAZE TEST; MEMORY; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PASSIVE AVOIDANCE; PRIORITY JOURNAL; RAT;

ADMINISTRATION, ORAL; AMNESIA; ANIMAL; AVOIDANCE LEARNING; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MEMORY, SHORT-TERM; MICE; OXYGEN CONSUMPTION; PROTIRELIN; RATS; RATS, INBRED STRAINS; SCOPOLAMINE;

EID: 0026036462     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.55.241     Document Type: Article

References (52)

1. Winokur, A. and Utiger, R.D.: Thyrotropinreleasing hormone: Regional distribution in rat brain. Science 185, 265-267 (1974)
2. Manaker, S., Winokur, A. and Rostene, W.H.: Autoradiographic localization of thyrotropin-releasing hormone receptors in the rat central nervous system. J. Neurosci. 5, 167-174 (1985)
3. Mantyh, P.W. and Hunt, S.P.: Thyrotropinreleasing hormone (TRH) receptors. Localization by light microscopic autoradiography in rat brain using 3H-[3-Me-His2] TRH as the radioligand. J. Neurosci. 5, 551-561 (1985)
4. Ogawa, N., Yamawaki, Y., Kuroda, H., Nukina, I., Ota, Z., Fujino, M. and Yanaihara, N.: Characteristics of thyrotropin releasing hormone (TRH) receptors in rat brain. Peptides 3, 669-677 (1982)
5. Yarbrough, O.G. and Pomara, N.: The therapeutic potential of thyrotropin releasing hormone (TRH) in Alzheimer's disease (AD). Prog. Neuropsychopharmacol. Biol. Psychiatry 9, 285-289 (1985)
6. Metcalf, G.: Regulatory peptide as a source of new drugs: The clinical prospects for analogues of TRH which are resistant to metabolic degradation. Brain Res. Rev. 4. 389-408 (1982)
7. Griffiths, E.C.: Clinical applications of thyrotropin-releasing hormone. Clin. Sci. 73, 449-457 (1987)
8. Fukuda, N., Saji, Y. and Nagawa, Y.: Behavioral and EEG alterations with brain stem compression and effect of thyrotropin-releasing hormone (TRH) in chronic cats. Folia Pharmacol. Japon. 75, 321-331 (1979) (Abs. in English)
9. Kastin, A.J., Ehrensing, R.H., Schalch, D.S. and Anderson, M.S.: Improvement in mental depression with decreased thyrotropin response after administration of thyrotropin releasing hormone. Lancet 11. 740-742 (1972)
10. Ogawa, N., Mizuno, S., Mori, A, Nukina, I., Ota, Z., and Yamamoto, M.: Potential anti-depressive effects of thyrotropin-releasing hormone (TRH) and its analogues. Peptides 5, 743-746 (1984)
11. Peabody, C A., Deblois, T.E. and Tinklenberg, J.R.: Thyrotropin-releasing hormone (TRH) and Alzheimer's disease. Am. J. Psychiatry 143, 262-263 (1986)
12. Inoue, H., Shimizu, T., Inamura, M., Takaishi, M. and Miyagawa, K.: The medical treatment of dementia. Geriat. Med. (Tokyo) 22, 801-803 (1984) (in Japanese)
13. Mellow, A.M., Sunderland, T., Cohen, R.M., Lawlor, B.A., Hill, J.L., Newhouse, P.A., Cohen, M.R. and Murphy, D.L.: Acute effects of highdose thyrotropin releasing hormone infusions in Alzheimer's disease. Psychopharmacology (Berlin) 98, 403-407 (1989)
14. Redding, T.W. and Schaily, A.V.: Studies on the inactivation of thyrotropin releasing hormone (TRH). Proc. Soc. Exp. Biol, 131, 415-419 (1969)
15. Fukuda, N., Saji, Y. and Nagawa, Y.: Pharmacological activities of TRH-T and its analog, DN-1417 in mice and rats.: Effects of oral administration. Japan. Pharmacol. Ther. 13, 57-66 (1985) (in Japanese)
16. Fukuda, N., Nishimura, O., Shikata, M., Hatanaka, G., Miyamoto, M., Saji, Y., Nakayama, R., Fujino, M. and Nagawa, Y.: Synthesis and pharmacology of TRH analogues to separate central nervous system action from endocrine activity. Chem. Pharm. Bull. (Tokyo) 28, 1667-1672 (1980)
17. Yamamoto, M. and Shimizu, M.: Effects of a new TRH analogue, YM-14673 on the centra) nervous system. Naunyn Schmiedebergs Arch. Pharmacol. 336, 561-565 (1987)
18. Brewster, D., Dettmar, P.W. and Metealf, G.: Biologically stable analogues of TRH with increased neuropharmacological potency. Neuro pharmacology 20, 497-503 (1981)
19. Suzuki, M., Sugano, H., Matsumoto, K., Yamamura, M. and Lshida, R.: Synthesis and central nervous system actions of thyrotropin-releasing hormone analogues containing a dihydroorotic acid moiety. J. Med. Chem. 33, 2130-2137 (1990)
20. Yamamura, M., Kinoshita, K., Nakagawa, H., Tanaka, T., Maeda, K. and Lshida, R.: Pharmacological study of TA-0910, a new thyrotropin-releasing hormone (TRH) analog, (1): Effects on the central nervous system by oral administration. Japan. J. Pharmacol. S3, 451-461 (1990)
21. Baratti, C.M., Huygens, P., Mino, J., Merlo, A. and Gardella, J., Jr.: Memory facilitation with posttrial injection of oxotremorine and physos tigmine in mice. Psychopharmacology (Berlin) 64, 85-88 (1979)
22. Bartus, R.T.: Evidence for a direct cholinergic involvement in the scopolamine-induced amnesia in monkeys: effects of concurrent administration of physostigminc and methylphenidate with scopolamine. Pharmacol. Biochem. Behav, 9, 833-836 (1978)
23. Rick, J.T., Whittle, K.L. and Cross, S.H.: Disruption and facilitation of cue discrimination in the rat by cholinergic agents. Neuropharmacology 20, 747-752(1981)
24. Sitaram, N, Weingartner, H. and Gillin, J.C.: Human serial learning: enhancement with areco-line and choline and impairment with scopolamine. Science 201, 274-276 (1978)
25. Kudo, Y., Sumikawa, H. and Lshida, R.: The potentiating effect of TA-0910, a new TRH analog, on the central muscarinic cholinergic system is probably in part due to its inhibition of desensi-tization of the muscarinic acetylcholine receptors. Japan. J. Pharmacol. 52. Supp. 1. 99P (1990)
26. Yamazaki, N., Shintani, M-, Saji, Y. and Nagawa, Y.: Effect of TRH and its analog DN-1417 on anoxia-induced amnesia in mice. Japan. J. Psychopharmacol. S, 1-9 (1985) (in Japanese)
27. Yamamoto, M. and Shimizu, M.: Effects of a new TRH analogue. YM-14673 on a passive avoidance test as a possible criterion of improvement in cognitive disturbance in rodents. Naunyn Schmiedebergs Arch. Pharmacol. 338, 262-267 (1988)
28. Santucci, A.C., Kanof, P.D. and Haroutunian, V.: Effect of physostigmine on memory consolidation and retrieval processes in intact and nucleus basalis-lesioned rats. Psychopharmacology (Berlin) 99, 70-74 (1989)
29. Whishaw, I.Q., O'Conner, W.T. and Dunnett, S.B.: Disruption of central cholinergic system in the rat by basal forebrain lesions or atropine: effect on feeding, sensorimotor behavior, locomotor activity and spatial navigation. Behav. Brain Res. 17, 103-115 (1985)
30. Bammer, G. and Chesher, G.B.: An analysis of some effects of ethanol on performance in a passive avoidance task. Psychopharmacology (Berlin) 77, 66-73 (1982)
31. De Groot, J.: The rat forebrain In stereotaxic coordinates. Verh. K. Acad. Wet. 52, 1-40 (1959)
32. Stanton, M.E., Thomas, G.J. and Brito, G.N.O.: Posterodorsal septal lesions impair performance on both shift and stay working memory tasks. Behav. Neurosci. 98, 405-415 (1984)
33. Overton, D.A.: Comparison of the degree of dis-criminability of various drugs using the T-maze drug discrimination paradigm. Psychopharmacology (Berlin) 76, 385-395 (1982)
34. Gellerman, L.W.: Chance orders of alternating stimulus in visual discrimination experiment. J. Genet. Psychol. 42. 206-208 (1933)
35. Le Poncin-Lafitte, M., Grosdemouge, C., RoyBillon, C., Potrat, P., Lespinasse, P. and Rapin, J.R.: Short-term memory and cerebral ischemia: Pharmacological application. Eur. Neurol. 20, 265-269 (1981)
36. Squire, L.R. and Barondes, S.H.: Variable decay of memory and its recovery in cycloheximide-treated mice. Proc. Natl. Acad. Sci. U.S.A. 69, 1416-1420 (1972)
37. Rigter, H., van Riezen, H- and de Wied, D.: The effects of ACTH- and vosopressin-analogues on COj-induced retrograde amnesia in rats. Physiol. Behav. 13. 381-388 (1974)
38. Baratti, C.M., Huygens, P., Mino, J., Merlo, A. and Gardella, J., Jr.: Memory facilitation with posttrial injection of oxotremorine and physostigmine in mice, Psychopharmacology (Berlin) 64, 85-88 (1979)
39. Miller, R.R. and Springer, A.D.: Amnesia, consolidation, and retrieval. Psychol. Rev. 0, 69-79 (1973)
40. Davies, P.: The neurochemistry of Alzheimer's disease and senile dementia. Med. Res. Rev. 3, 221-236 (1983)
41. Rossor, M.N., Iversen, L.L., Mountjoy, C.Q., Roth, M., Hawthorn, J., Ang, V.Y. and Jenkins, J.S.: Arginine vasopressin and choline acetyltrans-ferase in brains of patients with Alzheimer type senile dementia. Lancet 2, 1367-1368 (1980)
42. Whitehouse, P.J., Price, D.L., Struble, R.G., Clerk, A.W., Coyle, J.T., and Delong, M.R.: Alzheimer's disease and senile dementia: Loss of neurons in the basal forebrain. Science 215, 1237-1239 (1982)
43. Miyamoto, M., Shintani, M., Nagaoka, A. and Nagawa, Y.: Lesioning of the rat basal forebrain leads to memory impairments in passive and active avoidance tasks. Brain Res. 328, 97-104 (1985)
44. Miyamoto, M., Kato, J., Narumi, S. and Nagaoka, A.: Characteristics of memory impairment following lesioning of the basal forebrain and medial septal nucleus in rats. Brain Res. 419, 193E (1987)
45. Tamaki, Y. and Kameyama, Y.: Effects of TRH on aquisition and extinction of shuttle box-avoidance bahavior in Fischer344 rats. Pharmacol. Biochem. Behav. 16, 943-947 (1982)
46. Andrews, J.S. and Sahgal, A.: The effects of thyrotropin releasing hormone on a visual discrimination task in rats. Pharmacol. Biochem. Behav. 21, 715-719 (1984)
47. Yamazaki, N., Nagaoka, A. and Nagawa, Y.: Effect of thyrotropin-releasing hormone (TRH) and its analog DN-1417 on scopolamine-induced impairment of short-term memory in rats. Japan. J. Psychopharmacol. 6, 359-366 (1986) (in Japanese)
48. Murray, C.L. and Fibiger, H.C.: Pilocarpine and physostigmine attenuate spacial memory impairments produced by lesions of the nucleus basalis magnoccllularis. Behav. Neurosci. 100, 23-32 (1986)
49. Lo Conte, G., Bartolini, L., Casamenti, F., Marconcini-Pepeu, I. and Pepeu, G.: Lesions of cholinergic forebrain nuclei: Changes in avoidance behavior and scopolamine action. Pharmacol. Biochem. Behav. 17, 933-937 (1982)
50. Alpern, H.P. and Marriott, J.G.: Short-term memory: Facilitation and disruption with cholinergic agents. Physiol. Behav. 11, 571-575 (1973)
51. Johnston, M.V., McKinney, M. and Coyle, J.T.: Evidence for a cholinergic projection to neocortex from neurons in basal forebrain. Proc. Natl. Acad. Sci. U.S.A. 76. 5392-5396 (1979)
52. Araki, H., Uchiyama, Y., Kawashima, K. and Aihara, H.: Impairment of memory and changes in neurotransmitters induced by basal forebrain lesion in rats. Japan. J. Pharmacol. 41, 497-504 (1986)